Get emailed when IBRX changes direction
Insider selling: $4,361,404 sold by 6 insiders (30d)
Est. revisions:
+0.0%
(1 up, 1 down in 30d)
Factor Model (net -0.1)
Factor Model
net -0.1 1.0 / 10
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0
IBRX launches ANKTIVA commercially in Saudi Arabia
Watch: Monitor upcoming detailed 2026 revenue guidance and pipeline updates for sustained commercial expansion and profitability trajectory.
IBRX expanded ANKTIVA's commercial availability to Saudi Arabia for bladder and lung cancers with SFDA approval. It secured $75M non-dilutive funding, raising total capital to $375M, and converted $25M debt into 4.6M shares. Partnerships with Biopharma and Cigalah Healthcare support Middle East distribution.
This commercial launch and strong capital raise enhance IBRX's global market reach and financial footing, accelerating growth amid ongoing revenue momentum.
Evidence
2h ago
ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia
yahoo-finance
3d ago
D. Boral Capital main IBRX: Buy → Buy
11d ago
ImmunityBio, Inc. (IBRX) Posts Strong Preliminary Q1 Sales on ANKTIVA Momentum
yahoo-finance
33d ago
BTIG Sees Upside in ImmunityBio, Inc. (IBRX), Cites Strong 2026 ANKTIVA Sales Growth
yahoo-finance
6 older signals
Fundamentals & Data ▾
ImmunityBio, Inc.
Healthcare · Biotechnology
Mkt Cap
$8B
Beta
0.06
52w Range
$1.83 - $12.43
Short Interest
135.5M 35.8%
Days to Cover
4.9 +2%
Technicals
downtrend
from 52w Hi
-1.6%
1w return
+3.7%
Insiders
selling
0B / 5S
Analysts
mixed
EPS Estimate
$-0.07
+0.0% 30d
1up / 1dn
Est. Dispersion
57%
3 analysts
Analyst Target
$15
$11 - $23
Options P/C
0.07
Insider Cluster
sell cluster
0B / 2S
Fund Convergence
strong
Citadel, Renaissance, Two Sigma
Financials
Revenue
$38M +407% YoY
FCF
$-72M
Gross Margin
99%
Op Margin
-169%
Momentum:
decelerating
Top Holders
Citadel
$3M
Renaissance
$2M
Two Sigma
$2M
Recent Filings & Data
insider trade
23
net selling
· $4,361,404 sold
6 insiders · 23 transactions (30d)
Recent transactions
LAUER REGAN J · other
SOON-SHIONG PATRICK · exercise · $24,999,996
SIMON BARRY J. M.D. · sell · $900,788
SIMON BARRY J. M.D. · sell · $1,783,602
SELECKY CHRISTOBEL E. · sell · $250,000
SELECKY CHRISTOBEL E. · exercise · $74,500
SOON-SHIONG PATRICK · other
SIMON BARRY J. M.D. · other
ADCOCK RICHARD · other
SACHS DAVID C · other
LAUER REGAN J · other
SOON-SHIONG PATRICK · other
ADCOCK RICHARD · other
SACHS DAVID C · other
SIMON BARRY J. M.D. · sell · $989,364
SELECKY CHRISTOBEL E. · sell · $437,650
SELECKY CHRISTOBEL E. · exercise · $223,500
ADCOCK RICHARD · other
SACHS DAVID C · other
SIMON BARRY J. M.D. · exercise · $219,864
ADCOCK RICHARD · other
LAUER REGAN J · other
SOON-SHIONG PATRICK · exercise · $231,402,412
14 signals · latest 2h ago
Get alerted when IBRX changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.